IVGIX
Price
$22.97
Change
-$0.40 (-1.71%)
Updated
Feb 21 closing price
Net Assets
157.69M
RMFCX
Price
$57.23
Change
-$0.62 (-1.07%)
Updated
Feb 21 closing price
Net Assets
105.48B
Ad is loading...

IVGIX vs RMFCX

Header iconIVGIX vs RMFCX Comparison
Open Charts IVGIX vs RMFCXBanner chart's image
VY® Invesco Growth and Income I
Price$22.97
Change-$0.40 (-1.71%)
VolumeN/A
Net Assets157.69M
American Funds American Mutual R3
Price$57.23
Change-$0.62 (-1.07%)
VolumeN/A
Net Assets105.48B
IVGIX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IVGIX vs. RMFCX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVGIX is a Hold and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 105B vs. IVGIX (158M). IVGIX pays higher dividends than RMFCX: IVGIX (1.81) vs RMFCX (1.69). IVGIX was incepted earlier than RMFCX: IVGIX (19 years) vs RMFCX (23 years). IVGIX has a lower initial minimum investment than RMFCX: IVGIX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 11.03 vs. IVGIX (3.57). RMFCX return over 5 years is better than : 41.75 vs. IVGIX (11.26).
IVGIXRMFCXIVGIX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years23 years-
Gain YTD3.8904.83680%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets158M105B0%
Annual Yield % from dividends1.811.69107%
Returns for 1 year3.5711.0332%
Returns for 3 years-8.1919.69-42%
Returns for 5 years11.2641.7527%
Returns for 10 years-10.6564.83-16%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSTL25.75-0.40
-1.53%
Castle Biosciences
AHG1.30-0.03
-2.26%
Akso Health Group ADS
AGL3.52-0.10
-2.76%
agilon health
NTRA162.31-5.88
-3.50%
Natera
SPRC0.45-0.02
-4.37%
SciSparc Ltd